REMEDY CONTAINING PROPAPHENONE ANTIPODE

    公开(公告)号:JPS6442423A

    公开(公告)日:1989-02-14

    申请号:JP18567888

    申请日:1988-07-27

    Applicant: BASF AG

    Abstract: PURPOSE: To prepare an oral or a parenteral therapeutic agent, comprising a specific amount of an antipode of propafenone as an active ingredient, having antiarrhythmic actions and useful for treating cardiopathy. CONSTITUTION: This antiarrhythmic therapeutic agent comprises (S)-propafenone or (R)propafenone represented by the formula as an active ingredient. The active ingredient has the structure represented by the formula and is effective in the form of a hydrochloride in treating cardiac and circulatory diseases, especially heart rate disorders. The content of the active substance in the therapeutic agent is usually 0.1-50mg, preferably 0.2-20mg, especially 1-5mg dose at a time based on 1kg body weight in a propafenone pharmaceutical preparation. The (S)-propafenone having a stronger β-blocking actions than those of (R,S)-propafenone is used for tachycardiac arrhythmia accompanied with a high catecholamine level and further for patients without still undergoing treatment with a β-blocker.

Patent Agency Ranking